Treatment of chronic renal failure
117 results
1 - 100
Treatment of chronic renal failure - Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
- Anaemia of chronic disease (ACD)
- Drug treatment for hypertension
- Erythropoietin for chronic renal failure anaemia
- Proteinuria
- Chronic heart failure
ARB treatment of high CV risk patients- IgA nephropathy
- Growth hormone for children with chronic renal failure
- Hypocalcaemia, hypoparathyroidism and vitamin D deficiency
- Curable causes of cognitive challenges and memory disease
- Hyperglycaemic hyperosmolar syndrome
- Acute kidney injury
- Organ transplant recipient in primary health care
- Eye symptoms and signs of systemic diseases
- Glomerulonephrites
- Secondary hypertension
Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis- No benefit to addition of stenting for treatment of atherosclerotic renal artery stenosis
- Hyperkalaemia
- Increased blood creatinine concentration, eGFR and renal function tests
- Gout and pseudogout
- Short-bowel syndrome
- Polycystic kidney disease
- Furosemide to prevent or treat acute renal failure in adults
- Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease: Cochrane systematic review
- Cirrhosis of the liver
- Diabetic kidney disease (diabetic nephropathy)
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia
- Finerenone decreases hospitalization for heart failure in patients with type 2 diabetes and chronic kidney disease (NNT = 189/year)
- Tumours of haematopoietic and lymphoid tissues: general information
- Endovascular versus open surgical repair for complicated chronic Type B aortic dissection
- Skin colour changes and pigmentary disorders
- Dronedarone in the prevention of atrial fibrillation - Image
- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- Obstipation in the adult
- Statins for people with chronic kidney disease not requiring dialysis
- High-dose B-vitamins harmful to patients with diabetic nephropathy
- Statins for improving renal outcomes
- Schistosomiasis (bilharziasis)
- IV iron improves symptoms in chronic heart failure patients with iron deficiency
- Nephrotic syndrome
- Pruritus
- Interventions for chronic kidney disease in people with sickle cell disease
- Drugs commonly causing poisonings
- Hypernatraemia
- More evidence against antibiotics for acute asthma exacerbations
- Erythropoiesis‐stimulating agents for anaemia in chronic heart failure patients
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome
- Hypertension in elderly patients
- Early treatment with ACE inhibitors in acute myocardial infarction
- Benzodiazepines for the relief of breathlessness in advanced malignant and non‐malignant diseases in adults
- Interventions for managing taste disturbances
- Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants
- SBP of 120 instead of 140 in nondiabetic, high-risk elderly leads to significant benefits and some harms (SPRINT)
- Continuous infusion versus bolus injection of loop diuretics for acute heart failure
- Antitubercular medication in ambulatory care
- Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants
- Hypoglycaemia in the absence of diabetes in adults
- Oral antidiabetic drugs and GLP-1 analogues
- SGLT-2 inhibitors in type 2 diabetes
- Higher hemoglobin target with epoeitin alfa is harmful in CKD (CHOIR)
- Palliative treatment
- Chronic diseases and pregnancy
- Interventions for metabolic bone disease in children with chronic kidney disease
- High-dose barium enemas prevent recurrent diverticular bleeding
- Antiplatelet agents for chronic kidney disease
- Oral adsorbents for preventing or delaying the progression of chronic kidney disease
- Antidepressants for depression in physical illness
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Urinary tract infections
- Rosuvastatin does not improve outcomes in HF with average lipids
- Guidelines for when to consider mortality-reducing treatments for patients with type 2 diabetes
- Nipple discharge and mastitis in a non-lactating woman
- Normal and abnormal growth in childhood
- Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis